Any thoughts? What you guys think.
"Investigators concluded that, in regard to safety and tolerability, lumateperone had a safety profile that was favorable to risperidone, citing a lower mean weight increase and lower rates of discontinuation due to adverse events. "
I quite like the sound of that although it does sound like there is some weight gain, still I am excited for this to come out
‘’ The FDA has set a Prescription Drug User Fee Act ( PDUFA ) target date of September 27, 2019.’’
is lumateperone can use off label for treatment resistant depression like other antipsychotics
Lumateperone is on Phase 3 for Bipolar Depression.